| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
- PIM447
-
- $113.00
-
2026-07-15
- CAS:1210608-43-7
- Purity: 98.97%
- Supply Ability: 10g
- PIM447
-
- $113.00
-
2026-07-15
- CAS:1210608-43-7
- Purity: 98.97%
- Supply Ability: 10g
- PIM447
-
- $118.00
-
2025-06-30
- CAS:1210608-43-7
- Purity: 98.97%
- Supply Ability: 10g
|
| | N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide Basic information |
| Product Name: | N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide | | Synonyms: | N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide;PIM447 (LGH447);PIM447 (LGH447) Free Base;EOS-60671;2-Pyridinecarboxamide, N-[4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]-3-pyridinyl]-6-(2,6-difluorophenyl)-5-fluoro-;PIM447;N-[4-[(1R,3S,5S)-3-Amino-5-methylcyclohexyl]-3-pyridinyl]-6-(2,6-difluorophenyl)-5-fluoro-2-pyridinecarboxamide (ACI) | | CAS: | 1210608-43-7 | | MF: | C24H23F3N4O | | MW: | 440.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1210608-43-7.mol |  |
| | N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide Chemical Properties |
| Boiling point | 493.7±45.0 °C(Predicted) | | density | 1.290±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:88.0(Max Conc. mg/mL);199.79(Max Conc. mM) Ethanol:88.0(Max Conc. mg/mL);199.79(Max Conc. mM) | | form | Solid | | pka | 1.35±0.70(Predicted) | | color | White to off-white |
| | N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide Usage And Synthesis |
| Uses | PIM kinases promote growth and survival of tumor cells and are expressed in a wide variety of human cancers. These kinases are potential therapeutic targets. PIM447 is a PIM kinase inhibitor. | | in vivo | PIM447 (100 mg/kg; p.o.; 5 times for a week) reduces tumor burden[2]. | Animal Model: | 6-week-old female NOD-SCID-IL-2Rγ/(NSG) mice (bearing RPMI-8226-luc cells)[2] | | Dosage: | 100 mg/kg | | Administration: | p.o.; 5 times for a week | | Result: | Clearly controlled tumor progression as measured by bioluminescence. |
| | IC 50 | PIM1; PIM2; PIM3 |
| | N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide Preparation Products And Raw materials |
|